Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1487 of 5804
-
Broccoli power: could a veggie extract shield smokers from cancer?
Prevention Recruiting nowThis phase II trial tests whether broccoli seed and sprout extract works to break down cancer causing substances of tobacco in heavy smokers. Smokers are at increased risk for developing lung, head and neck, and other cancers. Broccoli seed and sprout extract may help break down …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
New pill aims to quiet diabetic nerve pain
Symptom relief CompletedThe purpose of this study is to investigate the safety and efficacy of the current hard gelatin capsule formulation of NRD135S.E1 80 mg once daily in the treatment of PDPN when administered for 13 weeks.
Phase: PHASE2 • Sponsor: James P. Rathmell, MD • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Tablet tech could transform breast cancer diagnosis in nigeria
Diagnosis Recruiting nowThe purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsi…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for Hard-to-Treat cancers: drug targets KRAS G12D mutation
Disease control OngoingThe study is being conducted to evaluate the safety and tolerability of HRS-4642 in patients with advanced solid tumors harboring KRAS G12D mutation.To estimate the maximum tolerated dose (MTD) and/or a biologically active dose (eg, recommended phase 2 dose \[RP2D\]) within inves…
Phase: PHASE1 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:00 UTC
-
Could flickering light slow Alzheimer's? new study seeks answers
Symptom relief Recruiting nowThe ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Inv…
Phase: NA • Sponsor: Zealand University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New Stent-Like device aims to seal brain aneurysms without surgery
Disease control OngoingThe objective of this study is to generate contemporaneous clinical data to facilitate a reasonable comparison of the performance of the FRED™ X™ device with the performance of the FRED™ device. The data generated from this study will be compared to the safety and effectiveness o…
Phase: NA • Sponsor: Microvention-Terumo, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a smartphone-guided exercise program help people with Parkinson's walk better and stay active?
Disease control CompletedThis study aims to determine the effects of a motor-cognitive exercise intervention, delivered in the home environment using eHealth methods, among people with Parkinson's disease. The intervention will support and motivate motor training, combined with cognitive training, aimed …
Phase: NA • Sponsor: Stiftelsen Stockholms Sjukhem • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could stem cells tame brain inflammation? new study tracks Real-World results
Disease control OngoingThis is a prospective, non-randomized, observational registry study evaluating the clinical outcomes of patients with autoimmune or post-infectious neuroinflammatory syndromes receiving stem cell-derived biologics (including mesenchymal stem cells and exosomes) at Biocells Medica…
Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 26, 2026 14:12 UTC
-
New drug combo aims to boost chemoradiation for head and neck cancer
Disease control Recruiting nowThis phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients with head and neck cancer. Ipatasertib is in a class of medications called prote…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Heart shield: statins may keep cancer therapy on track
Disease control Recruiting nowThis study proposes that the addition of statins reduces the treatment delays or early discontinuations secondary to cardiotoxicity in patients with Stage I-III HER2 positive breast being treated with anti-HER2 therapy.
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New combo approach slashes post-surgery heart rhythm risk
Disease control CompletedPostoperative atrial fibrillation (POAF) is a common complication following cardiac surgery with an estimated incidence around 35%. It has been found to be an independent predictor of 30-day and 6-month mortality, stroke, renal failure, respiratory failure, and need for permanent…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Experimental drug combo targets tough brain cancers
Disease control CompletedThe aim of this clinical trial is to evaluate the safety, preliminary effectiveness, and pharmacokinetic profiles of SM-1 (Obitrexate Fumarate Enteric-coated Pellet Capsules) combined with temozolomide, and conduct systematic dose exploration for the treatment of refractory or re…
Phase: PHASE1 • Sponsor: Shenzhen Zhenxing Medical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a simple diet prevent Crohn's Flare-Ups after surgery?
Disease control Recruiting nowOver the past 10 years, there are a large number of dietary treatments related to the CD, such as specific carbohydrate diet, low Fermentable Oligo-, Di-, Mono-saccharides And Polyols (FODMAP) diet, and allergen-free foods. But there is no consistent conclusion or convincing evid…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Lung transplant showdown: which surgical method wins?
Disease control Recruiting nowThe purpose of this research study is to compare the technique of performing bilateral lung transplantation off-pump vs venoarterial ECMO (VA ECMO). The goal of the trial is to determine which technique has lower rates of primary graft dysfunction.
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New lupus drug enpatoran tested for long-term safety
Disease control OngoingThe purpose of the study is to evaluate the long term safety and efficacy of orally administered M5049 in participants with subacute cutaneous lupus erythematosus (SCLE), discoid lupus erythematosus (DLE) and/or systemic lupus erythematosus (SLE) who have completed the 24 week tr…
Phase: PHASE2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New vaccine strategy could shield spleenless patients from deadly infection
Disease control Recruiting nowThe purpose of the study is to evaluate the immunological response and tolerance of 3 vaccine strategies against meningococcus B, a potentially fatal invasive infection.
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New knee injection shows promise for arthritis pain relief
Symptom relief CompletedAn open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular injections of RTX-GRT7039 in patients who have pain associated with osteoarthritis of the knee despite standard of care.
Phase: PHASE3 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Iodine gel may stop cavities from coming back in kids
Prevention Recruiting nowThis is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New chemo cocktail aims to tame tough childhood kidney cancer
Disease control Recruiting nowThis is a multicenter, interventional, non-randomized study among patients with a relapsed or refractory Wilms tumor. The study will aim to assess efficacy of metronomic chemotherapy, in terms of disease control after two cycles of metronomic chemotherapy.
Phase: PHASE1, PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New implant offers hope for glaucoma patients failing drops
Disease control OngoingThe objective of this early feasibility clinical study is to evaluate the safety and effectiveness of several different GORE Glaucoma Drainage Implant configurations in subjects with primary open-angle glaucoma that is uncontrolled by hypotensive medications or for which conventi…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC